I'm looking for information about
Can't find what you're looking for? You may need to login to see more documents.
Suggested parameters and sets of instructions outlining best practices and standards for accomplishing specific duties.
Children in Research
IRBMED
| Approval Date:
March 8, 2021 3:00 pm
The involvement of children of any age in human subjects research involves additional regulatory and ethical considerations. Resources on the main categories for consideration follow.
Children are persons who have not attained the legal age for consent to treatments or procedures involved in the research, under the applicable law of the jurisdiction in which the research will be conducted (45 CFR 46.402)
Neonates (less than 28 days of age)
- Regulations: Research Involving Neonates of uncertain viability, and nonviable neonates (45 CFR
46.205) - Research on viable neonates is covered under regulations on child subjects, 45 CFR 46 Subpart D (.401 and following)
Assent (pediatric participant's agreement to participate in research)
Guidance and Resources in Research A-Z
- Assent of Children in Research
- Assent Template – recommended for children ages 10- to 14-years-old
- Assent Guidelines – tool demonstrating common IRB determinations for when assent is required, based on the age of the participant and whether the study offers the prospect of direct benefit
Office of Human Research Protections (OHRP)
- Regulations: Additional Protections for Children Involved as Subjects in Research (45 CFR 46, Subpart D)
- Frequently Asked Questions: Children in Research
- Research with Children: What Parents Need to Know – 7-minute video
- Special Protections for Children as Research Subjects (Overview of the 4 regulations under which child subjects are permitted)
- Research involving greater risk than ‘minor increase over minimal’ without direct benefit to participants – Guidance for 45 CFR 46.407
Food and Drug Administration (FDA)
- Regulations: Additional Safeguards for Children in Clinical Investigations (21 CFR 50, Subpart D)
- General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products (“Pediatric Drug Development” Draft Guidance 2022)
Other
- National Cancer Institute Guidance: Children’s Assent Information directed at parents, and in ‘plain language,’ on the process and meaning of children’s assent; illustrative for all types of research.
- NIH Inclusion Across the Lifespan Policy – Applications and proposals involving human subjects research must address plans for including individuals across the lifespan in the PHS Human Subjects and Clinical Trial Information Form. Any age-related exclusions must include a rationale and justification based on a scientific or ethical basis.
- Wards of the State as Research Subjects – There are both state and federal laws that regulate what is allowed and what must be done when a ward participates in a research study.
Questions?
Contact us at [email protected] or 734-763-4768 / (Fax 734-763-1234)
2800 Plymouth Road, Building 520, Room 3214, Ann Arbor, MI 48109-2800
A list of IRBMED staff is available at our website.
Edited By: [email protected]
Last Updated: November 17, 2023 3:00 PM